Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11554
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, Shu Fenen
dc.contributor.authorNewland, Lisaen
dc.contributor.authorJohn, Thomasen
dc.contributor.authorWhite, Shane Cen
dc.date.accessioned2015-05-16T01:10:06Z
dc.date.available2015-05-16T01:10:06Z
dc.date.issued2012-08-31en
dc.identifier.citationJournal of Medical Case Reports 2012; 6(): 261en
dc.identifier.govdoc22937937en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11554en
dc.description.abstractVasculitis has been associated with malignancies, more commonly hematological rather than solid malignancies. Due to the rarity of these conditions and the lack of a temporal association, the relationship between vasculitis and malignancy remains unclear. Paraneoplastic vasculitis as a phenomenon of lung cancer has been described in the literature. To the best of our knowledge, this is the first case report of leukocytoclastic vasculitis being an initial presentation of malignant pleural mesothelioma.We report the case of an 84-year old Greek man who presented to our facility with an erythematous, pruritic and purpuric rash affecting his limbs. This was biopsy-proven to be leukocytoclastic vasculitis and treated conservatively with topical corticosteroids as well as oral prednisolone, with good results. Six months later, he was diagnosed as having malignant pleural mesothelioma. As he remained asymptomatic from his malignancy, no systemic chemotherapy was instituted. He had a recurrence of biopsy-proven leukocytoclastic vasculitis two months after he was diagnosed as having mesothelioma, which again settled with conservative measures.It is important to remain vigilant with regard to the association between leukocytoclastic vasculitis and malignancies. A diagnosis of vasculitis requires a search for malignancies as well as other possible etiologies. This is particularly of relevance when the vasculitis becomes chronic, recurrent or treatment is no longer effective. Should our patient have experienced refractory vasculitis, we would have instituted systemic chemotherapy to treat the underlying malignancy.en
dc.language.isoenen
dc.titleParaneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of medical case reportsen
dc.identifier.affiliationAustin Health, Department of Medical Oncology, 145 Studley Road, Heidelberg, Victoria, 3084, Australiaen
dc.identifier.doi10.1186/1752-1947-6-261en
dc.description.pages261en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/22937937en
dc.type.austinJournal Articleen
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Files in This Item:
File Description SizeFormat 
22937937.pdf905.45 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

14
checked on Jan 29, 2023

Download(s)

38
checked on Jan 29, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.